A detailed history of Hrt Financial LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 78,927 shares of ZNTL stock, worth $254,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,927
Holding current value
$254,144
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.9 - $4.57 $228,888 - $360,696
78,927 New
78,927 $289,000
Q1 2024

May 13, 2024

BUY
$10.83 - $16.49 $1.23 Million - $1.88 Million
113,750 New
113,750 $1.79 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $183M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.